BACKGROUND: Skin and soft tissue infections (SSTIs) caused by Achromobacter xylosoxidans are very infrequent. The aim of the present study was to investigate the clinical and microbiological characteristics of this infection. METHODS: We carried out a retrospective review of 14 cases of SSTI due to A. xylosoxidans that occurred at the University Hospital of Guadalajara (Spain) from January 2007 to December 2012. RESULTS: The infection was secondary to vascular diseases, trauma, and recent surgery in 12 patients (85.7%). The most frequent clinical presentation was infection of a vascular ulcer (5 cases). The infection was monomicrobial in 7 patients (50%) and 9 cases were community-acquired (64.2%). The clinical outcome of the patients was uniformly good after antibiotic treatment, except in 4 patients who suffered recurrence of the infection. CONCLUSION: A. xylosoxidans should be considered a potential pathogen in patients with SSTIs, especially in patients with vascular diseases or after surgery or trauma. A history of contact with water should be investigated in all cases. Treatment can be difficult due to the high level of antibiotic resistance. Trimethoprim-sulfamethoxazole may be useful for treatment in outpatients with community-acquired infections.
BACKGROUND: Skin and soft tissue infections (SSTIs) caused by Achromobacter xylosoxidans are very infrequent. The aim of the present study was to investigate the clinical and microbiological characteristics of this infection. METHODS: We carried out a retrospective review of 14 cases of SSTI due to A. xylosoxidans that occurred at the University Hospital of Guadalajara (Spain) from January 2007 to December 2012. RESULTS: The infection was secondary to vascular diseases, trauma, and recent surgery in 12 patients (85.7%). The most frequent clinical presentation was infection of a vascular ulcer (5 cases). The infection was monomicrobial in 7 patients (50%) and 9 cases were community-acquired (64.2%). The clinical outcome of the patients was uniformly good after antibiotic treatment, except in 4 patients who suffered recurrence of the infection. CONCLUSION:A. xylosoxidans should be considered a potential pathogen in patients with SSTIs, especially in patients with vascular diseases or after surgery or trauma. A history of contact with water should be investigated in all cases. Treatment can be difficult due to the high level of antibiotic resistance. Trimethoprim-sulfamethoxazole may be useful for treatment in outpatients with community-acquired infections.
Authors: Julia Dai; Auris O Huen; Lori A Kestenbaum; Margaret D Sarezky; Carrie C Coughlin; Albert C Yan Journal: Pediatr Dermatol Date: 2015-05-14 Impact factor: 1.588
Authors: Burcu Isler; Timothy J Kidd; Adam G Stewart; Patrick Harris; David L Paterson Journal: Antimicrob Agents Chemother Date: 2020-10-20 Impact factor: 5.191
Authors: Marco Toscano; Roberta De Grandi; Diego Giampietro Peroni; Enzo Grossi; Valentina Facchin; Pasquale Comberiati; Lorenzo Drago Journal: BMC Microbiol Date: 2017-09-25 Impact factor: 3.605
Authors: Jane H Kim; Paul R Ruegger; Elyson Gavin Lebig; Samantha VanSchalkwyk; Daniel R Jeske; Ansel Hsiao; James Borneman; Manuela Martins-Green Journal: Front Cell Infect Microbiol Date: 2020-06-03 Impact factor: 5.293
Authors: E Pérez Barragán; J Sandino Pérez; L Corbella; M A Orellana; M Fernández-Ruiz Journal: Rev Esp Quimioter Date: 2018-05-23 Impact factor: 1.553